Intuitive Surgical tops Q3 estimates but discloses $450M antitrust settlement and narrows procedure-growth outlook; shares tumble 6.5% (Oct 21)

What happened

Intuitive Surgical reported third-quarter results that topped analysts' estimates, but the surgical robot maker also disclosed a $450 million antitrust settlement and narrowed its procedure-growth outlook. Shares tumbled 6.5% in premarket trading Wednesday.

Who’s affected

• Intuitive Surgical (ISRG) — -6.5% premarket; hit by both the settlement disclosure and the narrowed growth outlook. Medical-device/robotics peers — antitrust scrutiny read-through. Healthcare sector — another large-cap medical name repricing growth expectations this season.

Sources

barrons.com